Revance Therapeutics (RVNC) Stock Highlights

3.8 | +1.06%

2024-11-21 04:51:31

Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are Product and the Service Segment. The Products segment generates maximum revenue which is engaged in the research and development of aesthetic and therapeutic products.

Statistics

Range Today

3.68 3.92

Volume Today 1.47M

Range 1 Year

2.3 9.74

Volume 1 Year 653.75M

Range 3 Year

2.3 37.98

Volume 3 Year 1.29B

Range 10 Year

2.3 42.41

Volume 10 Year 1.99B

Highlights

Market Capitalization 388.14M (small)

Floating Shares 91.28M

Current Price 3.8

Price To Earnings -1.92

Price To Revenue 2.7

Earnings Per Share -2.2

Payout Ratio 0%

Performance

Latest +1.06%

1 Month -28.03%

3 Months -42.6%

6 Months +25%

1 Year -49.47%

3 Years -72.36%

5 Years -76.41%

10 Years -76.16%

Benchmarks

Market Capitalization

169 / 368

Gross Profits

173 / 278

Total Revenue

57 / 300

Total Rank

249 / 368

Free Cashflow

308 / 352

Performance 5 years

212 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.